In a first round of funding, Life Sciences Partners III, BiomedInvest AG and Novartis Venture Fund have invested EUR 7.2m in Okairos AG. The financing will enable the company to demonstrate proof of concept of its adenovirus-based technology in several indications.
GP also announced the refinancing of online gardening retailer YouGardem, scoring a 60% cost return
CDP Venture and Tim Ventures take part in the round, alongside Club Digital and Club Italia Investimenti 2
Deal is the second from Bid Equity II, which held a close in November 2019 and targets B2B software
Early-stage investor Italian Angels for Growth and Swiss holding company Brahma also take part in the round